Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
826
-
Total 13F shares, excl. options
-
175M
-
Shares change
-
+4.05M
-
Total reported value, excl. options
-
$25.5B
-
Value change
-
+$595M
-
Put/Call ratio
-
0.78
-
Number of buys
-
354
-
Number of sells
-
-365
-
Price
-
$145.57
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2018
917 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2018.
Edwards Lifesciences Corp - Common Stock (EW) has 826 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175M shares
of 590M outstanding shares and own 29.66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21.5M shares), BlackRock Inc. (15.5M shares), STATE STREET CORP (8.24M shares), Bank of New York Mellon Corp (7.47M shares), SANDS CAPITAL MANAGEMENT, LLC (6.92M shares), FMR LLC (6.71M shares), WELLINGTON MANAGEMENT GROUP LLP (6.34M shares), ALLIANCEBERNSTEIN L.P. (4.81M shares), BROWN ADVISORY INC (3.87M shares), and NORGES BANK (3.38M shares).
This table shows the top 826 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.